What Phenox Inc does

Phenox Inc. is the US distribution subsidiary of phenox GmbH, a privately-held medical device company founded in 2005 and headquartered in Bochum, Germany. The company develops and distributes interventional devices for the treatment of neurovascular diseases, with a particular focus on acute ischemic stroke, hemorrhagic stroke, and complex intracranial aneurysms. Its US operations are headquartered in Irvine, California, with manufacturing executed through two partners: Wallaby Medical in Laguna Hills, California (producing Avenir, Esperance, Pilote, and pNOVUS 17) and phenox Limited in Galway, Ireland (producing pRESET, pNOVUS 21, and pORTAL).

The product portfolio is structured as an integrated treatment ecosystem across three clinical categories. Acute ischemic stroke devices include the pRESET mechanical thrombectomy device (helical slit design with dual-type cells for clot integration) and the Esperance Aspiration Catheter. Hemorrhagic stroke is addressed via the Avenir Coil System and Avenir Uno (handle-free detachment, 62 ultra-soft coil sizes). Access and delivery devices — pNOVUS Microcatheter, pORTAL 14 Microguidewire (ASACOR torque technology), Pilote Long Sheath, and Esperance Distal Access Catheter — are designed for navigation in tortuous anatomies. Aneurysm treatment is supported by the p64 Flow Modulation Device and pCONUS Bifurcation Aneurysm Implant.

Phenox generates revenue through direct hardware sales of these devices to hospitals, stroke treatment centers, and endovascular specialists, with distribution in the United States handled exclusively through phenox Inc. The company employs an enterprise field sales motion, supported by marketing activity at medical conferences and industry events, and operates alongside affiliated entities under the "WallabyPhenox" brand umbrella.

Name

Phenox Inc

Legal name

phenox Inc.

Website

https://phenox.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Phenox Inc. is the US distribution arm of phenox GmbH, a privately-held medical device company that develops and sells a portfolio of neurovascular interventional devices — including mechanical thrombectomy, aspiration catheters, embolic coils, and access devices — directly to hospitals and endovascular specialists for treating ischemic and hemorrhagic stroke.

Ownership category

akta.pro rank

Product category

Neurovascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)

akta.pro secondary industry

Stroke & Vascular Neurology (HLAKAIAG)

Keywords

• Neurovascular medical devices
• Mechanical thrombectomy devices
• Embolization coil systems
• Stroke treatment devices
• Microcatheter access devices

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Neurovascular Medical Device Sales: Phenox generates revenue through the sale of medical devices for treating neurovascular diseases including thrombectomy devices, aneurysm implants, aspiration catheters, microcatheters, and guidewires. Products are sold to hospitals and endovascular specialists performing stroke procedures.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Phenox develops, manufactures, and distributes neurovascular interventional devices for the treatment of ischemic and hemorrhagic stroke, intracranial aneurysms, and dissections. The portfolio includes mechanical thrombectomy devices (pRESET), aspiration catheters (Esperance), embolic coil systems (Avenir, Avenir Uno), flow modulation and bifurcation implants (p64, pCONUS), and access/delivery devices (pNOVUS, pORTAL, Pilote, Esperance Distal Access Catheter). Products are sold to hospitals and endovascular specialists performing neurovascular procedures.

Product overview

Phenox Inc is a medical device company specializing in neurovascular treatments for stroke. The product portfolio consists of a comprehensive suite of interventional devices organized into three main categories: Acute Ischemic Stroke Devices (thrombectomy and aspiration catheters including pRESET and Esperance Aspiration Catheter), Hemorrhagic Stroke Devices (coiling systems including Avenir Coil System and Avenir Uno), and Access Devices (microcatheters, microguidewires, and sheaths including pNOVUS, pORTAL, Pilote Long Sheath, and Esperance Distal Access Catheter). Additionally, the company offers advanced aneurysm treatment devices including the p64 Flow Modulation Device and pCONUS Bifurcation Aneurysm Implant. These devices work together as an integrated treatment ecosystem where access devices facilitate navigation to treatment sites, and treatment devices address the specific stroke pathology.

Differentiator

Problem solved

Functional benefit

Products and services

• Esperance Aspiration Catheter Aspiration catheter designed for acute ischemic stroke treatment, used by endovascular specialists to remove blood clots from cerebral arteries through suction-based thrombectomy procedures.
• pRESET Thrombectomy Device Mechanical thrombectomy device with a helical slit design, proximal closed ring, and dual type cells for clot integration and retrieval in tortuous anatomies, used for acute ischemic stroke treatment.
• Avenir Coil System Embolic coil system for aneurysm treatment featuring a handle-free instant detachment mechanism, ultra soft coils with 62 sizes of unparalleled softness, a complete portfolio of 7 versatile softness classes, 2 shapes, and 2 coil diameters.
• Avenir Uno Embolic Coils Embolic coils designed for small diameters and longer lengths, featuring purpose-built precision coil shapes, finisher softness for dense packing, and procedural efficiency in small spaces.
• Esperance Distal Access Catheter Distal access catheter for accessing cerebral vasculature during neurovascular procedures, providing support and trackability for device delivery.
• Pilote Long Sheath Long sheath designed for difficult Type III arches, offering best-in-class trackability and tip softness with increased arch support to prevent catheter prolapse.
• pNOVUS Microcatheter Microcatheter featuring 14 transition zones for optimized balance and stable coil delivery, a 100cm proprietary coating for navigation through complex anatomy, and a lower profile (2.1F to 1.9F OD) for enhanced compatibility and crossing.
• pORTAL 14 Microguidewire Steerable hydrophilic microguidewire with ASACOR technology for maximum torque transmission, dock-extendable design with atraumatic tip, refined hydrophilic coating for lower vessel friction, seamless transition zones, and minimized whip effect and kink resistance via proprietary core alloy.
• p64 Flow Modulation Device Flow modulation device for the treatment of complex intracranial aneurysms and dissections, designed to redirect blood flow while maintaining patency of branch vessels.
• pCONUS Bifurcation Aneurysm Implant Bifurcation aneurysm implant intended to treat complex, wide neck intracranial bifurcation aneurysms by providing scaffold support at the aneurysm neck.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Wallaby MedicalcoreOEM/ Whitelabel/ Licensing PartnerWallaby Medical manufactures Avenir, Esperance, Pilote, and pNOVUS 17 products at their facility in Laguna Hills, CA. These products are then distributed by phenox Inc. in the US market. This is a manufacturing partnership where Wallaby produces devices that phenox distributes.

Scale indicators2 records

Recent moves1 record

Expansion highlights4 records

Emerging players

• Viz.ai: Viz.ai provides AI-enabled stroke detection and care coordination software that interfaces with neurointerventional workflow. While not a device competitor, it operates in the same stroke-treatment ecosystem and increasingly integrates with the same hospital customers.
• Rapid Medical: Rapid Medical develops adjustable neurovascular devices including the Tigertriever stent retriever and Comaneci device. It competes with Phenox in the ischemic stroke and aneurysm spaces with differentiated adjustable-platform technology.
• Anaconda Biomed: Anaconda Biomed is developing next-generation stent retrievers ( ANA® device) for acute ischemic stroke. It competes in the same mechanical thrombectomy category as Phenox's pRESET, focused on improving clot retrieval efficacy.

Direct peers

• Penumbra, Inc. Penumbra is a direct competitor in the neurovascular space with its aspiration thrombectomy systems (Penumbra System, RED catheters) for acute ischemic stroke. Both companies compete head-to-head in aspiration-based clot retrieval and share the same neurointerventionalist customer base.

Broad incumbents

• Stryker (Neurovascular): Stryker's Neurovascular division offers the Trevo stent retriever and a broader portfolio including Target coils and the Neuroform stent. Stryker is a broad incumbent with significantly larger sales reach that competes with Phenox in mechanical thrombectomy and aneurysm treatment.
• Balt Group: Balt is an established neurovascular company offering a broad portfolio of coils, stents, flow diverters, and access devices. It competes with Phenox across multiple categories, particularly in European and international markets.
• Medtronic (Neurovascular): Medtronic's neurovascular portfolio includes the Solitaire stent retriever, Pipeline flow diverter, and a full stroke care suite. As a large incumbent with bundled hospital contracts, Medtronic competes with Phenox across multiple device categories.
• Johnson & Johnson (Cerenovus): Cerenovus, J&J's neurovascular franchise, offers the Embotrap stent retriever, Galaxy coils, and a complete stroke intervention portfolio. It directly competes with Phenox in thrombectomy, coiling, and access devices.

Regional players

• MicroPort NeuroTech: MicroPort's neurovascular division (historically including assets from the Aryton acquisition) competes in the Chinese and APAC markets with intracranial stents and revascularization devices, overlapping with Phenox's portfolio in select international geographies.

Others

• Wallaby Medical: Wallaby Medical is Phenox's manufacturing partner (WallabyPhenox DBA) and produces several products Phenox distributes in the US. While not a direct commercial competitor, the operational and strategic interdependence makes it a closely linked counterparty.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/phenox-usa

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phenox Inc